Ken Fisher Abcam PLC Transaction History

Fisher Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$21.54 - $24.41 $9.95 Million - $11.3 Million	-461,853 Reduced 56.94%	349,266 $7.9 Million
Q2 2023 Dec 12, 2023	BUY	$12.62 - $24.47 $5.83 Million - $11.3 Million	461,853 Added 132.24%	811,119 $19.8 Million
Q2 2023 Aug 08, 2023	BUY	$12.62 - $24.47 $6,814 - $13,213	540 Added 0.07%	811,119 $19.8 Million
Q1 2023 Dec 12, 2023	BUY	$12.98 - $17.1 $5.99 Million - $7.89 Million	461,313 Added 132.08%	810,579 $10.9 Million
Q1 2023 May 01, 2023	BUY	$12.98 - $17.1 $475,976 - $627,057	36,670 Added 4.74%	810,579 $10.9 Million
Q4 2022 Feb 03, 2023	BUY	$13.92 - $17.0 $10.8 Million - $13.2 Million	773,909 New	773,909 $12 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.